X4 Pharmaceuticals Raises $37.5M in Series A Financing
X4 Pharmaceuticals, a Cambridge, Mass.-based clinical stage biotechnology company, raised $37.5m in Series A financing. Maxim Merchant Capital, a wholly owned division of Maxim Group LLC, served as the sole placement agent for the financing, with Cormorant Asset Management serving…